Gene Activity List

Home

Stocks

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

eRecord

Gene Compound Experiment Study Pathway Assay Report Bug Request Feature

Gene Activity List

You are on Page 75 of 1714:

65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85

Gene	Compound	Assay	Inh	Ic50	Ki	View

calcium channel, voltage-dependent, gamma subunit 5	LYSERGOL	Calcium Channel Type L, Phenylalkylamine	44%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 4	LYSERGOL	Calcium Channel Type L, Phenylalkylamine	44%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 3	LYSERGOL	Calcium Channel Type L, Phenylalkylamine	44%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 2	LYSERGOL	Calcium Channel Type L, Phenylalkylamine	44%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 1	LYSERGOL	Calcium Channel Type L, Phenylalkylamine	44%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 4 subunit	LYSERGOL	Calcium Channel Type L, Phenylalkylamine	44%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 3 subunit	LYSERGOL	Calcium Channel Type L, Phenylalkylamine	44%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 2 subunit	LYSERGOL	Calcium Channel Type L, Phenylalkylamine	44%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1S subunit	LYSERGOL	Calcium Channel Type L, Phenylalkylamine	44%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, alpha2/delta subunit 1	ROSIGLITAZONE	Calcium Channel Type L, Dihydropyridine	47%	NoneNone	NoneNone	View
Sigma-2 Receptor	PERGOLIDE	Sigma2	47%	NoneNone	NoneNone	View
adrenergic receptor, alpha 2a	PHENELZINE	Adrenergic alpha2A	47%	NoneNone	NoneNone	View
Cytochrom P450-1A2 monooxygenase	HALCINONIDE	CYP450-1A2 Inhibition	47%	NoneNone	NoneNone	View
melanocortin 4 receptor	ECONAZOLE	Melanocortin MC4	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	KETOCONAZOLE	Calcium Channel Type L, Phenylalkylamine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 1 subunit	KETOCONAZOLE	Calcium Channel Type L, Phenylalkylamine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1E subunit	KETOCONAZOLE	Calcium Channel Type L, Phenylalkylamine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, N type, alpha 1B subunit	KETOCONAZOLE	Calcium Channel Type L, Phenylalkylamine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, alpha2/delta subunit 1	KETOCONAZOLE	Calcium Channel Type L, Phenylalkylamine	47%	NoneNone	NoneNone	View
opioid receptor, sigma 1	KETOCONAZOLE	Sigma1	47%	NoneNone	NoneNone	View
adrenergic receptor, alpha 1d (Non-specific probe)	KETOCONAZOLE	Adrenergic alpha1D	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 8	KETOCONAZOLE	Calcium Channel Type L, Phenylalkylamine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 7	KETOCONAZOLE	Calcium Channel Type L, Phenylalkylamine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 6	KETOCONAZOLE	Calcium Channel Type L, Phenylalkylamine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 5	KETOCONAZOLE	Calcium Channel Type L, Phenylalkylamine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 4	KETOCONAZOLE	Calcium Channel Type L, Phenylalkylamine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 3	KETOCONAZOLE	Calcium Channel Type L, Phenylalkylamine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 2	KETOCONAZOLE	Calcium Channel Type L, Phenylalkylamine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 1	KETOCONAZOLE	Calcium Channel Type L, Phenylalkylamine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 4 subunit	KETOCONAZOLE	Calcium Channel Type L, Phenylalkylamine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 3 subunit	KETOCONAZOLE	Calcium Channel Type L, Phenylalkylamine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 2 subunit	KETOCONAZOLE	Calcium Channel Type L, Phenylalkylamine	47%	NoneNone	NoneNone	View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase)	ACEMETACIN	CYP450-2C9 Inhibition	47%	NoneNone	NoneNone	View
cytochrome P450, family 2, subfamily C, polypeptide 9	ACEMETACIN	CYP450-2C9 Inhibition	47%	NoneNone	NoneNone	View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase)	RABEPRAZOLE	CYP450-2C9 Inhibition	47%	NoneNone	NoneNone	View
cytochrome P450, family 2, subfamily C, polypeptide 9	RABEPRAZOLE	CYP450-2C9 Inhibition	47%	NoneNone	NoneNone	View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase)	PHENYTOIN	CYP450-2C9 Inhibition	47%	NoneNone	NoneNone	View
cytochrome P450, family 2, subfamily C, polypeptide 9	PHENYTOIN	CYP450-2C9 Inhibition	47%	NoneNone	NoneNone	View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase)	MYCOPHENOLATE MOFETIL	CYP450-2C9 Inhibition	47%	NoneNone	NoneNone	View
cytochrome P450, family 2, subfamily C, polypeptide 9	MYCOPHENOLATE MOFETIL	CYP450-2C9 Inhibition	47%	NoneNone	NoneNone	View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase)	NATEGLINIDE	CYP450-2C9 Inhibition	47%	NoneNone	NoneNone	View
cytochrome P450, family 2, subfamily C, polypeptide 9	NATEGLINIDE	CYP450-2C9 Inhibition	47%	NoneNone	NoneNone	View
A3 adenosine receptor	THIORIDAZINE	Adenosine A3	47%	NoneNone	NoneNone	View
5-hydroxytryptamine (serotonin) receptor 2B	BUFLOMEDIL	Serotonin 5-HT2B	47%	NoneNone	NoneNone	View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	3,3',4',5-TETRACHLOROSALICYLANILIDE	Dopamine Transporter	47%	NoneNone	NoneNone	View
opioid receptor, sigma 1	PIPERILATE ETHOBROMIDE	Sigma1	47%	NoneNone	NoneNone	View
opioid receptor, kappa 1	ALPHA-ERGOCRYPTINE	Opiate kappa	47%	NoneNone	NoneNone	View
5-hydroxytryptamine (serotonin) receptor 2A	BITHIONOL	Serotonin 5-HT2A	47%	NoneNone	NoneNone	View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4	HUPERZINE A	Serotonin Transporter	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 8	DOBUTAMINE	Calcium Channel Type L, Benzothiazepine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 7	DOBUTAMINE	Calcium Channel Type L, Benzothiazepine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 6	DOBUTAMINE	Calcium Channel Type L, Benzothiazepine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 5	DOBUTAMINE	Calcium Channel Type L, Benzothiazepine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 4	DOBUTAMINE	Calcium Channel Type L, Benzothiazepine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 3	DOBUTAMINE	Calcium Channel Type L, Benzothiazepine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 2	DOBUTAMINE	Calcium Channel Type L, Benzothiazepine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 1	DOBUTAMINE	Calcium Channel Type L, Benzothiazepine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 4 subunit	DOBUTAMINE	Calcium Channel Type L, Benzothiazepine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 3 subunit	DOBUTAMINE	Calcium Channel Type L, Benzothiazepine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 2 subunit	DOBUTAMINE	Calcium Channel Type L, Benzothiazepine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1S subunit	DOBUTAMINE	Calcium Channel Type L, Benzothiazepine	47%	NoneNone	NoneNone	View
glycine receptor, beta subunit	TERFENADINE	Glycine, Strychnine-Sensitive	46%	NoneNone	NoneNone	View
glycine receptor, alpha 2 subunit	TERFENADINE	Glycine, Strychnine-Sensitive	46%	NoneNone	NoneNone	View
endothelin receptor type A	TERFENADINE	Endothelin ETA	46%	NoneNone	NoneNone	View
cytochrome P450, family 3, subfamily a, polypeptide 13	TRAZODONE	CYP450-3A4 Inhibition	46%	NoneNone	NoneNone	View
cytochrome P450, family 3, subfamily a, polypeptide 13	PROCHLORPERAZINE	CYP450-3A4 Inhibition	46%	NoneNone	NoneNone	View
Cytochrom P450-2C19 monooxygenase	PRAMOXINE	CYP450-2C19 Inhibition	46%	NoneNone	NoneNone	View
Cytochrom P450-2C19 monooxygenase	NABUMETONE	CYP450-2C19 Inhibition	46%	NoneNone	NoneNone	View
Cytochrom P450-2C19 monooxygenase	NALOXONAZINE	CYP450-2C19 Inhibition	46%	NoneNone	NoneNone	View
Cytochrom P450-2C19 monooxygenase	NALOXONE	CYP450-2C19 Inhibition	46%	NoneNone	NoneNone	View
A3 adenosine receptor	CINNARIZINE	Adenosine A3	46%	NoneNone	NoneNone	View
melanocortin 5 receptor	3,3',4',5-TETRACHLOROSALICYLANILIDE	Melanocortin MC5	46%	NoneNone	NoneNone	View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	FENBENDAZOLE	Dopamine Transporter	46%	NoneNone	NoneNone	View
adrenergic receptor, alpha 1b	KITASAMYCIN	Adrenergic alpha1B	46%	NoneNone	NoneNone	View
adrenergic receptor, alpha 2a	BROMHEXINE	Adrenergic alpha2A	46%	NoneNone	NoneNone	View
5-hydroxytryptamine (serotonin) receptor 1A	MAPROTILINE	Serotonin 5-HT1A	46%	NoneNone	NoneNone	View
5-hydroxytryptamine (serotonin) receptor 1B	QUETIAPINE	Serotonin 5-HT1B	46%	NoneNone	NoneNone	View
Sigma-2 Receptor	SPARTEINE	Sigma2	46%	NoneNone	NoneNone	View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3	NITRENDIPINE	Adenosine Transporter	46%	NoneNone	NoneNone	View
concentrative Na+ nucleoside cotransporter (DBSS)	NITRENDIPINE	Adenosine Transporter	46%	NoneNone	NoneNone	View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1	NITRENDIPINE	Adenosine Transporter	46%	NoneNone	NoneNone	View
adenine nucleotide translocase (DBSS) (Non-specific probe)	NITRENDIPINE	Adenosine Transporter	46%	NoneNone	NoneNone	View
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4	NITRENDIPINE	Adenosine Transporter	46%	NoneNone	NoneNone	View
dopamine receptor D4	TERCONAZOLE	Dopamine D4.2	46%	NoneNone	NoneNone	View
thromboxane A synthase 1	SULFINPYRAZONE	Thromboxane Synthetase	46%	NoneNone	NoneNone	View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A)	SULFINPYRAZONE	Thromboxane Synthetase	46%	NoneNone	NoneNone	View
cholinergic receptor, muscarinic 5	TERBINAFINE	Muscarinic M5	46%	NoneNone	NoneNone	View
5-hydroxytryptamine (serotonin) receptor 2C	TERBINAFINE	Serotonin 5-HT2C	46%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 8	SILDENAFIL	Calcium Channel Type L, Benzothiazepine	46%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 7	SILDENAFIL	Calcium Channel Type L, Benzothiazepine	46%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 6	SILDENAFIL	Calcium Channel Type L, Benzothiazepine	46%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 5	SILDENAFIL	Calcium Channel Type L, Benzothiazepine	46%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 4	SILDENAFIL	Calcium Channel Type L, Benzothiazepine	46%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 3	SILDENAFIL	Calcium Channel Type L, Benzothiazepine	46%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 2	SILDENAFIL	Calcium Channel Type L, Benzothiazepine	46%	NoneNone	NoneNone	View
adrenergic receptor, alpha 1a	QUINACRINE	Adrenergic alpha1A	45%	NoneNone	NoneNone	View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4	NABUMETONE	Serotonin Transporter	45%	NoneNone	NoneNone	View
matrix metalloproteinase 1 (interstitial collagenase)	EPALRESTAT	Protease, Matrix Metalloprotease-1 (MMP-1)	45%	NoneNone	NoneNone	View
phosphodiesterase 4A, cAMP specific	OXICONAZOLE	Phosphodiesterase PDE4	45%	NoneNone	NoneNone	View
phosphodiesterase 4C, cAMP-specific	OXICONAZOLE	Phosphodiesterase PDE4	45%	NoneNone	NoneNone	View
phosphodiesterase 4D	OXICONAZOLE	Phosphodiesterase PDE4	45%	NoneNone	NoneNone	View
phosphodiesterase 4B, cAMP specific	OXICONAZOLE	Phosphodiesterase PDE4	45%	NoneNone	NoneNone	View
phosphodiesterase 3B	OXICONAZOLE	Phosphodiesterase PDE3	45%	NoneNone	NoneNone	View
phosphodiesterase 3A	OXICONAZOLE	Phosphodiesterase PDE3	45%	NoneNone	NoneNone	View
Sigma-2 Receptor	RIMANTADINE	Sigma2	45%	NoneNone	NoneNone	View
matrix metallopeptidase 9	NIFURSOL	Protease, Matrix Metalloprotease-9 (MMP-9)	45%	NoneNone	NoneNone	View
matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)	NIFURSOL	Protease, Matrix Metalloprotease-9 (MMP-9)	45%	NoneNone	NoneNone	View
matrix metalloproteinase 1 (interstitial collagenase)	NIFURSOL	Protease, Matrix Metalloprotease-1 (MMP-1)	45%	NoneNone	NoneNone	View
phosphodiesterase 3B	CETYLPYRIDINIUM BROMIDE	Phosphodiesterase PDE3	45%	NoneNone	NoneNone	View
phosphodiesterase 3A	CETYLPYRIDINIUM BROMIDE	Phosphodiesterase PDE3	45%	NoneNone	NoneNone	View
arginine vasopressin receptor 1A	BENZETHONIUM CHLORIDE	Vasopressin V1A	45%	NoneNone	NoneNone	View
histamine receptor H 1	PHENTOLAMINE	Histamine H1, Central	45%	NoneNone	NoneNone	View
chemokine (C-C motif) receptor 2	NISOLDIPINE	Chemokine CCR2B	45%	NoneNone	NoneNone	View
phosphodiesterase 5A, cGMP-specific	CADMIUM ACETATE	Phosphodiesterase PDE5	45%	NoneNone	NoneNone	View
phosphodiesterase 5A, cGMP-specific	CADMIUM ACETATE	Phosphodiesterase PDE5	45%	NoneNone	NoneNone	View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2	DROPERIDOL	Adrenergic, Norepinephrine Transporter	45%	NoneNone	NoneNone	View
Cytochrom P450-1A2 monooxygenase	ERGONOVINE	CYP450-1A2 Inhibition	45%	NoneNone	NoneNone	View
melanocortin 4 receptor	CLOMIPRAMINE	Melanocortin MC4	45%	NoneNone	NoneNone	View
nitric oxide synthase 3 (endothelial cell)	BENZOTHIAZYL DISULFIDE	Nitric Oxide Synthase, Constitutive (cNOS)	45%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 7	FLEROXACIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 6	FLEROXACIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 5	FLEROXACIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 4	FLEROXACIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 3	FLEROXACIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 2	FLEROXACIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 1	FLEROXACIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 4 subunit	FLEROXACIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 3 subunit	FLEROXACIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 2 subunit	FLEROXACIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1S subunit	FLEROXACIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, alpha 1F subunit	FLEROXACIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1D subunit	FLEROXACIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1C subunit	FLEROXACIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	FLEROXACIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 1 subunit	FLEROXACIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1E subunit	FLEROXACIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, N type, alpha 1B subunit	FLEROXACIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, alpha2/delta subunit 1	FLEROXACIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
opioid receptor, kappa 1	MIANSERIN	Opiate kappa	43%	NoneNone	NoneNone	View
5-hydroxytryptamine (serotonin) receptor 2C	MINOXIDIL	Serotonin 5-HT2C	43%	NoneNone	NoneNone	View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	MEPAZINE	Dopamine Transporter	43%	NoneNone	NoneNone	View
adrenergic receptor, alpha 2a	MEPAZINE	Imidazoline I2, Central	43%	NoneNone	NoneNone	View
adrenergic receptor, alpha 2c (Non-specific probe)	MEPAZINE	Imidazoline I2, Central	43%	NoneNone	NoneNone	View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE	Dopamine Transporter	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 8	DIELDRIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 7	DIELDRIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 6	DIELDRIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 5	DIELDRIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 4	DIELDRIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 3	DIELDRIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 2	DIELDRIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 1	DIELDRIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 4 subunit	DIELDRIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 3 subunit	DIELDRIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 2 subunit	DIELDRIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1S subunit	DIELDRIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, alpha 1F subunit	DIELDRIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1D subunit	DIELDRIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1C subunit	DIELDRIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	DIELDRIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 1 subunit	DIELDRIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1E subunit	DIELDRIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, N type, alpha 1B subunit	DIELDRIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, alpha2/delta subunit 1	DIELDRIN	Calcium Channel Type L, Dihydropyridine	43%	NoneNone	NoneNone	View
adrenergic receptor, beta 1	DOMPERIDONE	Adrenergic beta1	43%	NoneNone	NoneNone	View
epidermal growth factor receptor	2-HYDROXYPROPYL-BETA-CYCLODEXTRIN	Protein Tyrosine Kinase, EGF Receptor	43%	NoneNone	NoneNone	View
adrenergic receptor, beta 2	2-HYDROXYPROPYL-BETA-CYCLODEXTRIN	Adrenergic beta2	43%	NoneNone	NoneNone	View
adrenergic receptor, alpha 2b	AMLODIPINE	Adrenergic alpha2B	43%	NoneNone	NoneNone	View
5-hydroxytryptamine (serotonin) receptor 2C	AMLODIPINE	Serotonin 5-HT2C	43%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, alpha 1F subunit	DOBUTAMINE	Calcium Channel Type L, Benzothiazepine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1D subunit	DOBUTAMINE	Calcium Channel Type L, Benzothiazepine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1C subunit	DOBUTAMINE	Calcium Channel Type L, Benzothiazepine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	DOBUTAMINE	Calcium Channel Type L, Benzothiazepine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 1 subunit	DOBUTAMINE	Calcium Channel Type L, Benzothiazepine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1E subunit	DOBUTAMINE	Calcium Channel Type L, Benzothiazepine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, N type, alpha 1B subunit	DOBUTAMINE	Calcium Channel Type L, Benzothiazepine	47%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, alpha2/delta subunit 1	DOBUTAMINE	Calcium Channel Type L, Benzothiazepine	47%	NoneNone	NoneNone	View
adrenergic receptor, alpha 2a	DOBUTAMINE	Imidazoline I2, Central	47%	NoneNone	NoneNone	View
adrenergic receptor, alpha 2c (Non-specific probe)	DOBUTAMINE	Imidazoline I2, Central	47%	NoneNone	NoneNone	View
angiotensin II receptor, type 2	DIGITONIN	Angiotensin AT2	47%	NoneNone	NoneNone	View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	BROMHEXINE	Dopamine Transporter	47%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type IV, beta	BROMHEXINE	Sodium Channel, Site 2	47%	NoneNone	NoneNone	View
sodium channel associated protein 1	BROMHEXINE	Sodium Channel, Site 2	47%	NoneNone	NoneNone	View
sodium channel associated protein 2	BROMHEXINE	Sodium Channel, Site 2	47%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type III, beta	BROMHEXINE	Sodium Channel, Site 2	47%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type I, alpha	BROMHEXINE	Sodium Channel, Site 2	47%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type IX, alpha	BROMHEXINE	Sodium Channel, Site 2	47%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type VII, alpha	BROMHEXINE	Sodium Channel, Site 2	47%	NoneNone	NoneNone	View
amiloride-sensitive cation channel 5, intestinal	BROMHEXINE	Sodium Channel, Site 2	47%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type III, beta	BROMHEXINE	Sodium Channel, Site 2	47%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type VIII, alpha polypeptide	BROMHEXINE	Sodium Channel, Site 2	47%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type XI, alpha	BROMHEXINE	Sodium Channel, Site 2	47%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type I, beta	BROMHEXINE	Sodium Channel, Site 2	47%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type 10, alpha polypeptide	BROMHEXINE	Sodium Channel, Site 2	47%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type IV, alpha polypeptide	BROMHEXINE	Sodium Channel, Site 2	47%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type V, alpha polypeptide	BROMHEXINE	Sodium Channel, Site 2	47%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type II, beta	BROMHEXINE	Sodium Channel, Site 2	47%	NoneNone	NoneNone	View
sodium channel, nonvoltage-gated 1 alpha	BROMHEXINE	Sodium Channel, Site 2	47%	NoneNone	NoneNone	View
sodium channel, nonvoltage-gated 1 gamma	BROMHEXINE	Sodium Channel, Site 2	47%	NoneNone	NoneNone	View
sodium channel, nonvoltage-gated 1 beta	BROMHEXINE	Sodium Channel, Site 2	47%	NoneNone	NoneNone	View